Vitro Announces Construction Of A New Manufacturing Facility

Vitro Diagnostics, Inc. dba Vitro Biopharma, announced the beginning of construction of build-to-suit corporate headquarters in Golden Colorado. The new facility is located in the Coors Technology Center and will be used for manufacturing, research & development and administrative functions. It is designed to support manufacturing of the Company's human stem cell products for various commercial applications in medical research, pharmaceutical manufacturing and potentially for cell therapy of diabetes. The new facility is especially suited for FDA-compliant manufacturing in a modern and extensively controlled environment. The Company plans to lease the facility from a third party.

Dr. Jim Musick, Vitro's President and CEO, said, "We are very pleased to announce the beginning of construction of the new facility. While our present facility was adequate for R&D, we now require an expanded facility to provide stem cell products for medical applications that are manufactured to stringent specifications. We anticipate that the new corporate facility will allow expanded production of our stem cell-based products targeting specific markets in medical research, drug development and discovery."

About Vitro Diagnostics, Inc.
Vitro Diagnostics, Inc. dba Vitro Biopharma www.vitrodiag.com, has generated over 30 adult pancreatic stem cell lines that are distinct from the limited number of embryonic stem cell lines that are presently approved for federally funded research. These cell lines may have commercial application in drug development and discovery, diabetes research and therapy. The Company developed and manufactures the VITROCELL brand of human cell lines consisting of pancreatic-derived cell lines and related products that are sold for various research and commercial applications.

SOURCE: Vitro Diagnostics, Inc.